STOCK TITAN

NextGen Healthcare Reports Granting of Inducement Awards

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

NextGen Healthcare (NASDAQ: NXGN) announced the approval of inducement awards for David Sides and Srinivas Velamoor following their appointments as President & CEO and Chief Growth & Strategy Officer, respectively. Sides will receive 450,000 performance share units and 640,500 shares of restricted stock. Velamoor is set to receive 397,114 shares of restricted stock. These grants, effective September 22, 2021, are part of the company’s 2021 Employment Inducement Equity Incentive Award Plan, as per NASDAQ rules, aimed at attracting key talent.

Positive
  • Inducement awards approved for key executives to enhance leadership.
  • 450,000 performance share units awarded to CEO David Sides, aligning his interests with shareholders.
Negative
  • Potential dilution of shares due to the large number of stock awards granted.

ATLANTA--(BUSINESS WIRE)-- NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today stated that the Compensation Committee of the Company’s Board of Directors has approved the grant of inducement awards to David Sides, in connection with his appointment as the Company’s President and Chief Executive Officer, effective on September 22, 2021. In connection with his appointment as the Company’s Chief Growth and Strategy Officer effective on July 1, 2021, Srinivas Velamoor will be granted an inducement award. The awards will be effective September 22, 2021 and will be made under NextGen Healthcare’s 2021 Employment Inducement Equity Incentive Award Plan, which was approved by the Company’s Board of Directors under Nasdaq Marketplace Rule 5635(c)(4), for granting equity awards to new employees of NextGen Healthcare as an inducement to join the Company.

Mr. Sides awards will include 450,000 performance share units. The performance share units vest upon both the attainment of five separate pre-determined stock price milestones and continued service over a period of three years following the grant date. Mr. Sides will also receive an aggregate of 640,500 shares of restricted stock, of which 471,000 represent a special incentive award intended to compensate Mr. Sides for the value of his unvested equity at his previous employer. The restricted stock awards vest in three equal annual installments beginning on the first anniversary of the grant date, subject to Mr. Sides’ continued service with the Company through the applicable vesting date.

Mr. Velamoor will be granted 397,114 shares of restricted stock, which vest over four years as follows: 25% will vest on the first anniversary of Mr. Velamoor’s commencement of employment, and the remaining 75% will vest in six installments following each six-month period thereafter, subject to Mr. Velamoor’s continued service with the Company through each vesting date.

The grants will be made as an inducement that was a material component of the compensation for each of Mr. Sides and Mr. Velamoor and their acceptance of employment with the Company and were granted as employment inducement awards pursuant to NASDAQ Listing Rule 5635(c)(4).

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Media Contact

Tami Stegmaier

(949) 237-6083

tstegmaier@nextgen.com

Barrett Golden / Sharon Stern

Joele Frank, Wilkinson Brimmer Katcher

(212) 355-4449

nextgen-jf@joelefrank.com

Investor Relations Contact

Matthew Scalo

(415) 370-9202

mscalo@nextgen.com

Laurie Connell

(212) 378-7071

lconnell@mackenziepartners.com

Daniel Burch

(212) 929-5748

dburch@mackenziepartners.com

Source: NextGen Healthcare, Inc.

FAQ

What inducement awards did David Sides receive from NextGen Healthcare?

David Sides was awarded 450,000 performance share units and 640,500 shares of restricted stock.

When were the inducement awards for NextGen executives approved?

The inducement awards were approved on September 22, 2021.

What is the purpose of the inducement awards given to NXGN executives?

The awards are designed to attract and retain key talent within the company.

How does the inducement award structure for NextGen Healthcare executives work?

The performance share units vest upon meeting stock price milestones and service duration, while restricted stock vests in annual installments.

What is the significance of the 2021 Employment Inducement Equity Incentive Award Plan for NXGN?

This plan allows NextGen Healthcare to offer equity awards as incentives to new executives.

Nextgen Healthcare Inc

NASDAQ:NXGN

NXGN Rankings

NXGN Latest News

NXGN Stock Data

1.61B
54.60M
33.55%
81.44%
7.44%
Health Information Services
Healthcare
Link
United States
Atlanta